252 results on '"Shiratsuchi, Motoaki"'
Search Results
2. Endothelial function testing before conditioning therapy is useful for predicting transplant-related complications after allogeneic hematopoietic cell transplantation
3. Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin–aldosterone–angiotensin system inhibitors in patients with chronic myelogenous leukemia
4. Identification of a drug-response gene in multiple myeloma through longitudinal single-cell transcriptome sequencing
5. Transformation of follicular lymphoma to double-hit lymphoma during adjuvant chemotherapy for concurrent ovarian carcinoma
6. Acquired hemophilia A associated with autoimmune pancreatitis with serum IgG4 elevation
7. Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
8. Characteristics of Patients With Development of Large Granular Lymphocyte Expansion Among Dasatinib-Treated Patients With Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia After Allogeneic Stem Cell Transplantation
9. A Case of Lichen Planus After COVID-19 Vaccination
10. Endothelial function testing before conditioning therapy is useful for predicting transplant-related complications after allogeneic hematopoietic cell transplantation
11. Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia
12. Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation
13. Pore Formers of the Immune System
14. Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma
15. Circulating endothelial cells and endothelial progenitor cells as potential predictors of acute GVHD after allogeneic hematopoietic stem cell transplantation
16. Imatinib induces demethylation of miR-203 gene: An epigenetic mechanism of anti-tumor effect of imatinib
17. Different Risk Factors Related to Adenovirus- or BK Virus-Associated Hemorrhagic Cystitis following Allogeneic Stem Cell Transplantation
18. Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients
19. Killing machines: three pore-forming proteins of the immune system
20. Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
21. Extranodal Multiple Involvement of Enteropathy-Type T-Cell Lymphoma without Expression of CC Chemokine Receptor 7
22. Successful treatment of pure red cell aplasia and autoimmune cytopenia with cyclosporine and prednisolone in a patient with SjÖgren’s syndrome
23. Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation
24. Clinico-pathological characteristics of primary adrenal lymphomas – potential efficacy of autologous stem cell transplantation
25. Cover Image
26. Composite gastrointestinal lymphoma consisting of diffuse large B-cell lymphoma and peripheral T-cell lymphoma
27. Achievement of complete remission of refractory hairy cell leukemia by rituximab progressing after allogeneic hematopoietic stem cell transplantation
28. Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages
29. Schizophyllum commune sinusitis after allogeneic bone marrow transplantation for myelodysplastic syndrome: A case report and literature review
30. Long-term follow-up after nonmyeloablative allogeneic hematopoietic stem cell transplantation for systemic sclerosis
31. A novel mechanism in suppression of erythropoiesis during inflammation: a crucial role of RCAS1
32. Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness
33. AN 85-YEAR-OLD JAPANESE WOMAN WITH PHILADELPHIA CHROMOSOME–POSITIVE CHRONIC MYELOGENOUS LEUKEMIA WITH DEL (5Q) SUCCESSFULLY TREATED BY INTERMITTENT IMATINIB THERAPY
34. Re-entry of tumour B cells into the cycle of somatic mutation and isotype switching in follicular lymphoma
35. Clinical significance of telomerase activity in multiple myeloma
36. Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-β
37. Apoptosis resistance of mature neutrophils in a case of chronic neutrophilic leukaemia
38. Intestinal Behçet’s Disease with Primary Myelofibrosis Involving Trisomy 8
39. Upshaw-Schulman syndrome diagnosed during pregnancy complicated by reversible cerebral vasoconstriction syndrome
40. Tax-Targeting Dendritic Cell Therapy for ATL: A Phase Ia/Ib Clinical Study
41. Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients
42. Schizophyllum commune sinusitis after allogeneic bone marrow transplantation for myelodysplastic syndrome: A case report and literature review.
43. Methotrexate-associated lymphoproliferative disorders with angioimmunoblastic T-cell lymphoma-like features accompanied by gamma-heavy chain disease in a patient with rheumatoid arthritis
44. Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature
45. Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting
46. Regulation of expression and trafficking of perforin-2 by LPS and TNF-α
47. Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab
48. Comparison between Antiemetic Effects of Palonosetron and Granisetron on Chemotherapy-Induced Nausea and Vomiting in Japanese Patients Treated with R-CHOP
49. Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia
50. Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.